152 related articles for article (PubMed ID: 37441566)
21. Variants in NAA15 cause pediatric hypertrophic cardiomyopathy.
Ritter A; Berger JH; Deardorff M; Izumi K; Lin KY; Medne L; Ahrens-Nicklas RC
Am J Med Genet A; 2021 Jan; 185(1):228-233. PubMed ID: 33103328
[TBL] [Abstract][Full Text] [Related]
22. A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.
Van Damme P; Støve SI; Glomnes N; Gevaert K; Arnesen T
Mol Cell Proteomics; 2014 Aug; 13(8):2031-41. PubMed ID: 24408909
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
Magin RS; March ZM; Marmorstein R
J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
[TBL] [Abstract][Full Text] [Related]
24. NAA10-related syndrome.
Wu Y; Lyon GJ
Exp Mol Med; 2018 Jul; 50(7):1-10. PubMed ID: 30054457
[TBL] [Abstract][Full Text] [Related]
25. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.
Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
PLoS One; 2024; 19(5):e0301328. PubMed ID: 38713657
[TBL] [Abstract][Full Text] [Related]
26. Evaluating possible maternal effect lethality and genetic background effects in
Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
bioRxiv; 2024 Jan; ():. PubMed ID: 37163119
[TBL] [Abstract][Full Text] [Related]
27. The biological functions of Naa10 - From amino-terminal acetylation to human disease.
Dörfel MJ; Lyon GJ
Gene; 2015 Aug; 567(2):103-31. PubMed ID: 25987439
[TBL] [Abstract][Full Text] [Related]
28. Proteomic and genomic characterization of a yeast model for Ogden syndrome.
Dörfel MJ; Fang H; Crain J; Klingener M; Weiser J; Lyon GJ
Yeast; 2017 Jan; 34(1):19-37. PubMed ID: 27668839
[TBL] [Abstract][Full Text] [Related]
29. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α.
Kang J; Chun YS; Huh J; Park JW
Redox Biol; 2018 Oct; 19():364-374. PubMed ID: 30237125
[TBL] [Abstract][Full Text] [Related]
30.
Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
Elife; 2021 Aug; 10():. PubMed ID: 34355692
[TBL] [Abstract][Full Text] [Related]
31.
Johnston JJ; Williamson KA; Chou CM; Sapp JC; Ansari M; Chapman HM; Cooper DN; Dabir T; Dudley JN; Holt RJ; Ragge NK; Schäffer AA; Sen SK; Slavotinek AM; FitzPatrick DR; Glaser TM; Stewart F; Black GC; Biesecker LG
J Med Genet; 2019 Jul; 56(7):444-452. PubMed ID: 30842225
[TBL] [Abstract][Full Text] [Related]
32. A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.
Esmailpour T; Riazifar H; Liu L; Donkervoort S; Huang VH; Madaan S; Shoucri BM; Busch A; Wu J; Towbin A; Chadwick RB; Sequeira A; Vawter MP; Sun G; Johnston JJ; Biesecker LG; Kawaguchi R; Sun H; Kimonis V; Huang T
J Med Genet; 2014 Mar; 51(3):185-96. PubMed ID: 24431331
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects.
Myklebust LM; Van Damme P; Støve SI; Dörfel MJ; Abboud A; Kalvik TV; Grauffel C; Jonckheere V; Wu Y; Swensen J; Kaasa H; Liszczak G; Marmorstein R; Reuter N; Lyon GJ; Gevaert K; Arnesen T
Hum Mol Genet; 2015 Apr; 24(7):1956-76. PubMed ID: 25489052
[TBL] [Abstract][Full Text] [Related]
34. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
[TBL] [Abstract][Full Text] [Related]
35. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
Lee MN; Kweon HY; Oh GT
Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
[TBL] [Abstract][Full Text] [Related]
36. Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene.
Yan H; Shi Z; Wu Y; Xiao J; Gu Q; Yang Y; Li M; Gao K; Chen Y; Yang X; Ji H; Cao B; Duan R; Jiang Y; Wang J
BMC Med Genet; 2019 May; 20(1):80. PubMed ID: 31088393
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal adaptive behavioral outcomes in Ogden syndrome by seizure status and therapeutic intervention.
Makwana R; Christ C; Marchi E; Harpell R; Lyon GJ
Am J Med Genet A; 2024 May; ():e63651. PubMed ID: 38747166
[TBL] [Abstract][Full Text] [Related]
38. Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.
Varland S; Arnesen T
BMC Res Notes; 2018 Jun; 11(1):404. PubMed ID: 29929531
[TBL] [Abstract][Full Text] [Related]
39. A Case of
Mizuno Y; Ichikawa Y; Kawai S; Wakamiya T; Murakami H; Kurosawa K; Ueda H
CJC Pediatr Congenit Heart Dis; 2022 Dec; 1(6):270-273. PubMed ID: 37969489
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Chinese female patients with a heterozygous pathogenic
Cong Y; Jin H; Wu K; Wang H; Wang D
Front Genet; 2022; 13():900226. PubMed ID: 36046249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
